Table 4 Sensitivity, specificity, AUC, cut-off and asymptotic significance of parameters in study groups.
Healthy control vs. diabetic group without complications group | |||||
|---|---|---|---|---|---|
Sensitivity (%) | Specifity (%) | AUC | Cut-off | p | |
Adropin (ng/L) | 90 | 88.9 | 0.971 | 133 | < 0.001 |
miR-21 | 95.6 | 95 | 0.990 | 32.7 | < 0.001 |
HbA1c (%) | 71.1 | 95 | 0.921 | 6.1 | < 0.001 |
CIMT (mm) | 95.6 | 90 | 0.956 | 0.75 | < 0.001 |
Healthy control vs. diabetic group with microvascular complications group | |||||
|---|---|---|---|---|---|
Sensitivity (%) | Specifity (%) | AUC | Cut-off | p | |
Adropin (ng/L) | 95 | 95.8 | 0.990 | 116 | < 0.001 |
miR-21 | 100 | 100 | 1.000 | 38.9 | < 0.001 |
HbA1c (%) | 87.5 | 95 | 1.000 | 6.1 | < 0.001 |
CIMT (mm) | 100 | 100 | 0.966 | 0.9 | < 0.001 |
Healthy control vs. diabetic group with macrovascular complications group | |||||
|---|---|---|---|---|---|
Sensitivity (%) | Specifity (%) | AUC | Cut-off | p | |
Adropin (ng/L) | 100 | 100 | 1.00 | 92.8 | < 0.001 |
miR-21 | 100 | 100 | 1.00 | 50.3 | < 0.001 |
HbA1c (%) | 70 | 100 | 1.00 | 6.6 | < 0.001 |
CIMT (mm) | 100 | 100 | 0.918 | 0.9 | < 0.001 |
Healthy control vs. coronary artery disease without diabetes mellitus group | |||||
|---|---|---|---|---|---|
Sensitivity (%) | Specifity (%) | AUC | Cut-off | p | |
Adropin (ng/L) | 100 | 100 | 1.00 | 84.8 | < 0.001 |
miR-21 | 100 | 100 | 1.00 | 78.8 | < 0.001 |
CIMT (mm) | 94.7 | 100 | 0.997 | 0.9 | < 0.001 |